Analysts Have Conflicting Sentiments on These Healthcare Companies: CVS Health (CVS), Madrigal Pharmaceuticals (MDGL) and VolitionRX (VNRX)

Analysts have been eager to weigh in on the Healthcare sector with new ratings on CVS Health (CVS – Research Report), Madrigal Pharmaceuticals (MDGL – Research Report) and VolitionRX (VNRX – Research Report).

CVS Health (CVS)

In a report issued on November 17, Brian Tanquilut from Jefferies maintained a Buy rating on CVS Health, with a price target of $95.00. The company’s shares closed last Friday at $68.81, close to its 52-week low of $64.41.

According to TipRanks.com, Tanquilut is a 4-star analyst with an average return of 2.0% and a 48.9% success rate. Tanquilut covers the Healthcare sector, focusing on stocks such as Cross Country Healthcare, Walgreens Boots Alliance, and Oncology Institute, Inc.

CVS Health has an analyst consensus of Strong Buy, with a price target consensus of $87.20, representing a 26.5% upside. In a report issued on November 7, TD Cowen also maintained a Buy rating on the stock with a $102.00 price target.

See the top stocks recommended by analysts >>

Madrigal Pharmaceuticals (MDGL)

Jefferies analyst Akash Tewari maintained a Buy rating on Madrigal Pharmaceuticals today and set a price target of $340.00. The company’s shares closed last Friday at $176.66.

According to TipRanks.com, Tewari is a 5-star analyst with an average return of 16.2% and a 51.5% success rate. Tewari covers the Healthcare sector, focusing on stocks such as Zentalis Pharmaceuticals, BioMarin Pharmaceutical, and Apellis Pharmaceuticals.

Currently, the analyst consensus on Madrigal Pharmaceuticals is a Strong Buy with an average price target of $306.33, implying an 80.2% upside from current levels. In a report issued on November 6, TD Cowen also maintained a Buy rating on the stock with a $396.00 price target.

VolitionRX (VNRX)

In a report released today, Bruce Jackson from Benchmark Co. maintained a Hold rating on VolitionRX. The company’s shares closed last Friday at $0.75, close to its 52-week low of $0.58.

According to TipRanks.com, Jackson has 0 stars on 0-5 stars ranking scale with an average return of -16.1% and a 32.4% success rate. Jackson covers the Healthcare sector, focusing on stocks such as Belite Bio, Inc. ADR, Seelos Therapeutics, and Tenon Medical, Inc.

VolitionRX has an analyst consensus of Moderate Buy, with a price target consensus of $3.05.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Read More on CVS:

• Pharmageddon Post-Mortem: CVS (NYSE:CVS), Walgreens (NASDAQ:WBA) Unconcerned
• CVS Health price target lowered to $86 from $91 at RBC Capital
• CVS Health price target lowered to $86 from $88 at Mizuho
• OKTA Stock’s Sell-Off Presents an Opportunity
• CVS Stock (NYSE:CVS): Don’t Get Ruffled by the Market’s Unhealthy Response